A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against

Annapoorani Chockalingam1, Cindy E McKinney, Manuela Rinaldi

  • 1Department of Dairy and Animal Science, Pennsylvania State University, University Park, PA 16802, USA.

Insights

A novel synthetic peptide derived from human Bactericidal/permeability-increasing protein (BPI) shows antimicrobial activity against Gram-negative bacteria causing bovine mastitis. This peptide effectively neutralizes lipopolysaccharide (LPS), offering potential for new cattle infection treatments.

Area of Science:

  • Veterinary Medicine
  • Microbiology
  • Biochemistry

Background:

  • Gram-negative bacteria cause significant bovine mastitis cases, leading to severe systemic inflammation due to lipopolysaccharide (LPS).
  • Current treatments for Gram-negative infections and associated inflammation in cattle are suboptimal.
  • Bactericidal/permeability-increasing protein (BPI) is a human neutrophil protein with known antimicrobial and LPS-neutralizing capabilities.

Purpose of the Study:

  • To assess the antimicrobial efficacy of a synthetic peptide derived from human BPI against Gram-negative bacteria implicated in bovine mastitis.
  • To evaluate the peptide's ability to neutralize LPS and its activity in the presence of bovine serum and milk.

Main Methods:

  • A hybrid synthetic peptide combining bactericidal (amino acids 90-99) and LPS-neutralizing (amino acids 148-161) regions of human BPI was synthesized.
  • Broth microdilution assays were used to determine the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) against clinical isolates.
  • Functional assays assessed LPS neutralization and peptide activity in serum and milk.

Main Results:

  • The peptide exhibited antimicrobial activity against Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., and Pseudomonas aeruginosa, with MICs ranging from 16-256 µg/ml.
  • MBCs were comparable to MICs, indicating bactericidal action, though no effect was observed against Serratia marcescens.
  • The peptide retained activity in serum but was significantly impaired in milk, yet it completely neutralized LPS.

Conclusions:

  • The BPI-derived peptide demonstrates significant antimicrobial and LPS-neutralizing properties against key Gram-negative mastitis pathogens.
  • Its efficacy in serum but not milk suggests potential challenges for intramammary application, warranting further investigation.
  • These findings support the exploration of BPI-based therapeutics for treating Gram-negative infections in cattle.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...